Abstract
Introduction: Randomized controlled trials (RCT) of psychotherapeutic interventions have addressed depression and demoralization associated with acute coronary syndromes (ACS). The present trial introduces psychological well-being, an increasingly recognized factor in cardiovascular health, as a therapeutic target. Objective: This study was designed to determine whether the sequential combination of cognitive-behavioral therapy (CBT) and well-being therapy (WBT) may yield more favorable outcomes than an active control group (clinical management; CM) and to identify subgroups of patients at greater risk for cardiac negative outcomes. Methods: This multicenter RCT comparedCBT/WBT sequential combination versus CM, with up to 30 months of follow-up. One hundred consecutive depressed and/or demoralized patients (out of 740 initially screened by cardiologists after a first episode of ACS) were randomized to CBT/WBT associated with lifestyle suggestions (n = 50) and CM (n = 50). The main outcome measures included: severity of depressive symptoms according to the Clinical Interview for Depression, changes in subclinical psychological distress, well-being, and biomarkers, and medical complications and events. Results: CBT/WBT sequential combination was associated with a significant improvement in depressive symptoms compared to CM. In both groups, the benefits persisted at follow-up, even though the differences faded. Treatment was also related to a significant amelioration of biomarkers (platelet count, HDL, and D-dimer), whereas the 2 groups showed similar frequencies of adverse cardiac events. Conclusions: Addressing psychological well-being in the psychotherapeutic approach to ACS patients with depressive symptoms was found to entail important clinical benefits. It is argued that lifestyle changes geared toward cardiovascular health may be facilitated by a personalized approach that targets well-being.
Journal Section:
Editor's choice
References
1.
Carney
RM
, Freedland
KE
. Depression and coronary heart disease
. Nat Rev Cardiol
. 2017
Mar
;14
(3
):145
–55
.
[PubMed]
1759-50022.
Rafanelli
C
, Roncuzzi
R
, Milaneschi
Y
, Tomba
E
, Colistro
MC
, Pancaldi
LG
, et al.. Stressful life events, depression and demoralization as risk factors for acute coronary heart disease
. Psychother Psychosom
. 2005
;74
(3
):179
–84
.
[PubMed]
0033-31903.
Kuhlmann
SL
, Arolt
V
, Haverkamp
W
, Martus
P
, Ströhle
A
, Waltenberger
J
, et al.. Prevalence, 12-month prognosis, and clinical management need of depression in coronary heart disease patients
. Psychother Psychosom
. 2019
;88
(5
):300
–11
.
[PubMed]
0033-31904.
de Figueiredo
JM
, Frank
JD
. Subjective incompetence, the clinical hallmark of demoralization
. Compr Psychiatry
. 1982
Jul-Aug
;23
(4
):353
–63
.
[PubMed]
0010-440X5.
Kim
JM
, Stewart
R
, Lee
YS
, Lee
HJ
, Kim
MC
, Kim
JW
, et al.. Effect of escitalopram vs placebo treatment for depression on long-term cardiac outcomes in patients with acute coronary syndrome: a randomized clinical trial
. JAMA
. 2018
Jul
;320
(4
):350
–8
.
[PubMed]
0098-74846.
Reavell
J
, Hopkinson
M
, Clarkesmith
D
, Lane
DA
. Effectiveness of cognitive behavioral therapy for depression and anxiety in patients with cardiovascular disease: A systematic review and meta-analysis
. Psychosom Med
. 2018
Oct
;80
(8
):742
–53
.
[PubMed]
0033-31747.
Berkman
LF
, Blumenthal
J
, Burg
M
, Carney
RM
, Catellier
D
, Cowan
MJ
, et al.; Enhancing Recovery in Coronary Heart Disease Patients Investigators (ENRICHD)
. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial
. JAMA
. 2003
Jun
;289
(23
):3106
–16
.
[PubMed]
0098-74848.
Kubzansky
LD
, Huffman
JC
, Boehm
JK
, Hernandez
R
, Kim
ES
, Koga
HK
, et al.. Positive psychological well-being and cardiovascular disease: JACC health promotion series
. J Am Coll Cardiol
. 2018
Sep
;72
(12
):1382
–96
.
[PubMed]
0735-10979.
Fava
GA
. Well-being therapy: Treatment manual and clinical applications
. Basel, Switzerland
: Karger Medical & Scientific Publishers
; 2016
. 10.
Guidi
J
, Rafanelli
C
, Fava
GA
. The clinical role of well-being therapy
. Nord J Psychiatry
. 2018
Aug
;72
(6
):447
–53
.
[PubMed]
0803-948811.
Fava
GA
, Rafanelli
C
, Grandi
S
, Conti
S
, Belluardo
P
. Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings
. Arch Gen Psychiatry
. 1998
Sep
;55
(9
):816
–20
.
[PubMed]
0003-990X12.
American Psychiatric Association
. Diagnostic and Statistical Manual of Mental Disorders
. 4th ed., revised. Washington (DC)
: American Psychiatric Association
; 2000
.13.
Fava
GA
, Freyberger
HJ
, Bech
P
, Christodoulou
G
, Sensky
T
, Theorell
T
, et al.. Diagnostic criteria for use in psychosomatic research
. Psychother Psychosom
. 1995
;63
(1
):1
–8
.
[PubMed]
0033-319014.
Tang
EW
, Wong
CK
, Herbison
P
. Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome
. Am Heart J
. 2007
Jan
;153
(1
):29
–35
.
[PubMed]
0002-870315.
First
MB
, Spitzer
RL
, Gibbon
M
, Williams
J
. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, research version
. New York (NY)
: Biometrics Research, New York State Psychiatric Institute
; 2002
.16.
Porcelli
P
, Sonino
N
. Psychological Factors Affecting Medical Conditions. A New Classification for DSM-V. Advances in Psychosomatic Medicine
. Basel, Switzerland
: Karger
; 2007
. 17.
Tecuta
L
, Tomba
E
, Grandi
S
, Fava
GA
. Demoralization: a systematic review on its clinical characterization
. Psychol Med
. 2015
Mar
;45
(4
):673
–91
.
[PubMed]
0033-291718.
Galeazzi
GM
, Ferrari
S
, Mackinnon
A
, Rigatelli
M
. Interrater reliability, prevalence, and relation to ICD-10 diagnoses of the Diagnostic Criteria for Psychosomatic Research in consultation-liaison psychiatry patients
. Psychosomatics
. 2004
Sep-Oct
;45
(5
):386
–93
.
[PubMed]
0033-318219.
Paykel
ES
. The clinical interview for depression. Development, reliability and validity
. J Affect Disord
. 1985
Jul
;9
(1
):85
–96
.
[PubMed]
0165-032720.
Guidi
J
, Fava
GA
, Bech
P
, Paykel
E
. The Clinical Interview for Depression: a comprehensive review of studies and clinimetric properties
. Psychother Psychosom
. 2011
;80
(1
):10
–27
.
[PubMed]
0033-319021.
Hamilton
M
. Development of a rating scale for primary depressive illness
. Br J Soc Clin Psychol
. 1967
Dec
;6
(4
):278
–96
.
[PubMed]
0007-129322.
Carrozzino
D
, Patierno
C
, Fava
GA
, Guidi
J
. The Hamilton Rating Scales for Depression: a critical review of clinimetric properties of different versions
. Psychother Psychosom
. 2020
;89
(3
):133
–50
.
[PubMed]
0033-319023.
24.
Benasi
G
, Fava
GA
, Rafanelli
C
. Kellner’s Symptom Questionnaire, a highly sensitive patient-reported outcome measure: systematic review of clinimetric properties
. Psychother Psychosom
. 2020
;89
(2
):74
–89
.
[PubMed]
0033-319025.
Ryff
CD
. Happiness is everything, or is it? Explorations on the meaning of psychological well-being
. J Pers Soc Psychol
. 1989
;57
(6
):1069
–81
. 0022-351426.
Ryff
CD
. Psychological well-being revisited: advances in the science and practice of eudaimonia
. Psychother Psychosom
. 2014
;83
(1
):10
–28
.
[PubMed]
0033-319027.
Guidi
J
, Brakemeier
EL
, Bockting
CL
, Cosci
F
, Cuijpers
P
, Jarrett
RB
, et al.. Methodological recommendations for trials of psychological interventions
. Psychother Psychosom
. 2018
;87
(5
):276
–84
.
[PubMed]
0033-319028.
Cohen
J
. Statistical power analysis for the behavioral sciences
. New York (NY)
: Routledge Academic
; 1988
.29.
Brummett
BH
, Babyak
MA
, Barefoot
JC
, Bosworth
HB
, Clapp-Channing
NE
, Siegler
IC
, et al.. Social support and hostility as predictors of depressive symptoms in cardiac patients one month after hospitalization: a prospective study
. Psychosom Med
. 1998
Nov-Dec
;60
(6
):707
–13
.
[PubMed]
0033-317430.
Rafanelli
C
, Gostoli
S
, Tully
PJ
, Roncuzzi
R
. Hostility and the clinical course of outpatients with congestive heart failure
. Psychol Health
. 2016
;31
(2
):228
–38
.
[PubMed]
0887-044631.
von Känel
R
. Acute mental stress and hemostasis: when physiology becomes vascular harm
. Thromb Res
. 2015
Feb
;135
(1
):S52
–5
. 0049-384832.
Vinholt
PJ
, Hvas
AM
, Frederiksen
H
, Bathum
L
, Jørgensen
MK
, Nybo
M
. Platelet count is associated with cardiovascular disease, cancer and mortality: A population-based cohort study
. Thromb Res
. 2016
Dec
;148
:136
–42
.
[PubMed]
0049-384833.
Ishida
M
, Itoh
T
, Nakajima
S
, Ishikawa
Y
, Shimoda
Y
, Kimura
T
, et al.. A low early high-density lipoprotein cholesterol level is an independent predictor of in-hospital death in patients with acute coronary syndrome
. Intern Med
. 2019
Feb
;58
(3
):337
–43
.
[PubMed]
0918-291834.
Fava
GA
, Sonino
N
. Depression associated with medical illness
. CNS Drugs
. 1996
Oct
;5
(3
):175
–89
. 1172-704735.
Fava
GA
, Guidi
J
, Rafanelli
C
, Rickels
K
. The clinical inadequacy of the placebo model and the development of an alternative conceptual framework
. Psychother Psychosom
. 2017
;86
(6
):332
–40
.
[PubMed]
0033-319036.
Carvalho
AF
, Sharma
MS
, Brunoni
AR
, Vieta
E
, Fava
GA
. The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature
. Psychother Psychosom
. 2016
;85
(5
):270
–88
.
[PubMed]
0033-319037.
Fava
GA
, Rafanelli
C
. Iatrogenic factors in psychopathology
. Psychother Psychosom
. 2019
;88
(3
):129
–40
.
[PubMed]
0033-319038.
Grace
SL
, Medina-Inojosa
JR
, Thomas
RJ
, Krause
H
, Vickers-Douglas
KS
, Palmer
BA
, et al.. Antidepressant use by class: association with major adverse cardiac events in patients with coronary artery disease
. Psychother Psychosom
. 2018
;87
(2
):85
–94
.
[PubMed]
0033-319039.
Guidi
J
, Tomba
E
, Fava
GA
. The sequential integration of pharmacotherapy and psychotherapy in the treatment of major depressive disorder: a meta-analysis of the sequential model and a critical review of the literature
. Am J Psychiatry
. 2016
Feb
;173
(2
):128
–37
.
[PubMed]
0002-953X40.
Nierenberg
B
, Mayersohn
G
, Serpa
S
, Holovatyk
A
, Smith
E
, Cooper
S
. Application of well-being therapy to people with disability and chronic illness
. Rehabil Psychol
. 2016
Feb
;61
(1
):32
–43
.
[PubMed]
0090-555041.
Rafanelli
C
, Roncuzzi
R
, Finos
L
, Tossani
E
, Tomba
E
, Mangelli
L
, et al.. Psychological assessment in cardiac rehabilitation
. Psychother Psychosom
. 2003
Nov-Dec
;72
(6
):343
–9
.
[PubMed]
0033-319042.
Gostoli
S
, Roncuzzi
R
, Urbinati
S
, Morisky
DE
, Rafanelli
C
. Unhealthy behaviour modification, psychological distress, and 1-year survival in cardiac rehabilitation
. Br J Health Psychol
. 2016
Nov
;21
(4
):894
–916
.
[PubMed]
1359-107X43.
Gostoli
S
, Roncuzzi
R
, Urbinati
S
, Rafanelli
C
. Clinical and subclinical distress, quality of life and psychological well-being after cardiac rehabilitation
. Appl Psychol Health Well-Being
. 2017
Nov
;9
(3
):349
–69
.
[PubMed]
1758-084644.
Turk-Adawi
KI
, Oldridge
NB
, Tarima
SS
, Stason
WB
, Shepard
DS
. Cardiac rehabilitation enrollment among referred patients: patient and organizational factors
. J Cardiopulm Rehabil Prev
. 2014
Mar-Apr
;34
(2
):114
–22
.
[PubMed]
1932-750145.
Zullo
MD
, Gathright
EC
, Dolansky
MA
, Josephson
RA
, Cheruvu
VK
, Hughes
JW
. The influence of depression on utilization of cardiac rehabilitation post-myocardial infarction: A study of 158,991 Medicare Beneficiaries
. J Cardiopulm Rehabil Prev
. 2017
Jan
;37
(1
):22
–9
.
[PubMed]
1932-750146.
Rippe
JM
. Are we ready to practice lifestyle medicine
. Am J Med
. 2019
Jan
;132
(1
):6
–8
.
[PubMed]
0002-9343© 2020 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2020
You do not currently have access to this content.
